Masimo (NASDAQ: MASI) announced today the FDA clearance of SedLine ® brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance ...

New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia Media Contact: Masimo Evan Lamb 949-396-3376 [email protected] ...

The FDA has FDA cleared Masimo Corp's (NASDAQ: MASI) SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. SedLine helps clinicians ...

In 2013, Masimo introduced the Root ® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and ...

In 2013, Masimo introduced the Root ® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and ...

The technologies involved included O3 regional oximetry, capnography with NomoLine sampling lines, SedLine brain function monitoring and multiple rainbow Pulse CO-Oximetry measurements.

The cerebral function monitor is a monitoring device which records integrated encephalograms (EEGs on slow-running paper), allowing continuous observations of cerebral activity for prolonged periods.

Patients in the pEEG group (n=150) had their brain function monitored, from the moment they entered the OR to arrival in the ICU, using Masimo SedLine.

06 September 2023By MEED Editorial Provision of neo-natal cerebral function monitoring equipment ...